Advertisement

Therapie: Theoretische Grundlagen und klinische Praxis

  • A. Delini-Stula
  • B. Woggon
  • H. M. Emrich
  • M. Dose
  • E. M. Steinmeyer
  • R. de Jong-Meyer
  • A.-E. Meyer
  • U. Wirth
Chapter
  • 17 Downloads

Zusammenfassung

Im Jahre 1959 sagte Provost Saunders bei der Eröffnung des Symposiums „A Pharmacological Approach for the Study of the Mind“ folgendes:

„... in the rational use of drugs in the treatment of mental illness, it is necessary to possess as full an understanding of the effects of these drugs on behavior as a whole, on the particular functions of the central nervous system, and on nerve structures, both anatomical and biochemical“ (S.xi–xii).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Carroll BJ (1983) Neurobiologie dimensions of depression and mania. In: Angst J (ed) The origins of depression: Current concepts and approaches. Springer, Berlin Heidelberg New York Tokyo, pp 163–196Google Scholar
  2. Delini-Stula A (1974) Excitatory behavior induced by combined pargyline-reserpine treatment – an experimental model of mania? Psihofarmakologija 3, Proceedings of the 3rd Yugoslav Psychopharmacological Symposium. Med Nak, pp 57–65Google Scholar
  3. Delini-Stula A (1978) Differential effects of baclofen and muscimol on behavioural responses implicating GABA-ergic transmission. GABA-Neurotransmitters, Alfred-Benzon-Symposium, 12. Munksgaard, pp 482–499Google Scholar
  4. Delini-Stula A (1980) Drug-induced alterations in animal behavior as a tool for the evaluation of antidepressants: Correlation with biochemical effects. In: Hoffmeister F, Stille G (eds) Psychotropic agents, part I: Antipsychotics and antidepressants. Springer, Berlin Heidelberg New York, pp 505–526Google Scholar
  5. Delini-Stula A, Meier M (1976) Inhibitory effects of propanolol and Oxprenolol on excitation induced by a MAO inhibitor and reserpine in the mouse. Neuropharmacology 15: 383–388PubMedGoogle Scholar
  6. Delini-Stula A, Radeke E (1985) Behavioral and pharmacological characterisation of tryptamine- induced excitation syndrome in rats. In: Boulton AA, Bieck PR, Maitre L, Riederer P (eds) Neuropsychopharmacology of the trace amines. Experimental and clinical aspects. Humana, Clifton/NJ, pp 125–140Google Scholar
  7. Delini-Stula A, Vassout A (1979) Differential effects of psychoactive drugs on aggressive responses in mice and rats. In: Sandler M (ed) Psychopharmacology of aggression. Raven, New York, pp 41–60Google Scholar
  8. Delini-Stula A, Vassout A (1981) The effects of antidepressants on aggressiveness induced by social deprivation in mice. Pharmacol Biochem Behav 14 [Suppl 1]: 33–41PubMedGoogle Scholar
  9. Delini-Stula A, Fischbach R, Gauthier J-M, Richou H, Rothweiler G, Wendt G, Wolfersdorf M (1987) First clinical experience with ifoxetine. A new 5-HT reuptake blocker with particular emphasis on the side-effect profile of the 5-HT-uptake inhibiting drugs. Int Clin Psychopharmacology 2: 201–215Google Scholar
  10. Emrich HM (1986) Alternativen zur Lithium-Prophylaxe. In: Müller-Oerlinghausen B, Greil W (Hrsg) Die Lithiumtherapie: Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York Tokyo, S 356–368Google Scholar
  11. Emrich HM, Altmann H, Dose M, Zerssen D v (1983) Therapeutic effect of GABA-ergic drugs in affective disorder: A prehminary report. Pharmacol Biochem Behav 19: 369–327PubMedGoogle Scholar
  12. File SE (1980) The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 2: 219–238PubMedGoogle Scholar
  13. Gardner CR (1986) Recent developments in 5-HT-related pharmacology of animal models of anxiety. Pharmacol Biochem Behav 24: 1479–1485PubMedGoogle Scholar
  14. Garzon J, Del Rio J (1981) Hyperactivity induced in rats by long-term isolation: Further studies on a new animal model for the detection of antidepressants. Eur J Pharmacol 74: 287–294PubMedGoogle Scholar
  15. Gray JA, Davis N, Feldon J, Nicholas J, Rawlins P, Owen SR (1981) Animal models of anxiety. Prog Neuropsychopharmacol 5: 143–157PubMedGoogle Scholar
  16. Jaekel J (1976) Wirkungen von Psychopharmaka auf soziales und individuelles Verhalten von Tieren. Fortschritte der Veterinärmedizin 25: 61–65Google Scholar
  17. Klerman GL (1975) Relationship between preclinical testing and therapeutic evaluation of antidepressant drugs: The importance of new animal models for theory and practice. In: Sudilowsky A, Gershon S, Beer B (eds) Predictability in psychopharmacology: Preclinical and clinical correlations. Raven, New York, pp 159–176Google Scholar
  18. Kraemer GW (1986) Causes of changes in brain noradrenaline systems and later effects on responses to social stressors in rhesus monkeys: The cascade of hypothesis. In: Antidepressants and receptor function. CIBA Foundation Symposium 123. Wiley, New York, pp 216–233Google Scholar
  19. Kraemer GW, Eber MH, Lake CR, McKinney WT (1984) Cerebrospinal fluid measures of neurotransmitter changes associated with pharmacological alteration of the despair response to social separation in rhesus monkeys. Psychiatry Res 11: 303–315PubMedGoogle Scholar
  20. Maitre L, Baumann PA, de Herdt P, Waldmeier PC (1985) On the interaction of carbamazepine with catecholamine metabohsm: Implication of psychopharmacological and behavioural effects. In: Pichot P, Berner P, Wolf R, Thau K (eds) Psychiatry. The state of the art, vol 3. Plenum, New York London, pp 437–444Google Scholar
  21. Mason ST, Fibiger HC (1979) Current Concepts. 1. Anxiety: The locus coeruleus disconnection. Life Sci 25: 2141–2147PubMedGoogle Scholar
  22. McKinney WT (1974) Primate social isolation: Psychiatric implications. Arch Gen Psychiatry 31: 422–426PubMedGoogle Scholar
  23. Olpe HR, Jones RSG (1983) The action of anticonvulsant drugs on the firing of locus coeruleus neurons: Selective, activating effect of carbamazepine. Eur J Pharmacol 91: 107–109PubMedGoogle Scholar
  24. Petty F, Sherman AD, Sacquitine L (1982) Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 16: 449–454PubMedGoogle Scholar
  25. Porsolt RD (1983) Pharmacological models of depression. In: Angst J (ed) The origins of depression: Current concepts and approaches. Springer, Berlin Heidelberg New York Tokyo, pp 313–330Google Scholar
  26. Porsolt RD, Pichon CM, Jalfre M (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature 266: 730–732PubMedGoogle Scholar
  27. Post RM, Uhde WT, Ballenger JC (1984) The efficacy of carbamazepine in affective illness. In: Usdin E, Asberg, M, Bertilsson L, Sjöqvist F (eds) Frontiers in biochemical and pharmacological research in depression. Raven, New York, pp 421–437Google Scholar
  28. Post RM, Rubinow DR, Ballenger JC (1986) Conditioning and sensitisation in the longitudinal course of affective illness. Br J Psychiatry 149: 191–201PubMedGoogle Scholar
  29. Randrup A, Kjellberg B, Schiorring E, Scheel-Krüger J, Fog R, Munkvad I (1980) Stereotyped behavior and its relevance for testing neuroleptics. In: Hoffmeister F, Stille G (eds) Psychotropic agents, part I: Antipsychotics and antidepressants. Springer, Berlin Heidelberg New York, pp 97–110Google Scholar
  30. Saunders P (1959) Introductory remarks: In: Featherstone R, Thomas C (eds) A pharmacologic approach to the study of the mind. Thomas, Springfield, pp xi-xiiGoogle Scholar
  31. Seligman MEP (1972) Learned helplessness. Ann Rev Med 23: 407–412PubMedGoogle Scholar
  32. Seligman MEP (1975) Helplessness. Freeman, San FranciscoGoogle Scholar
  33. Seligman MEP, Groves D (1970) Non-transient learned helplessness. Psychonom Sci 19: 191–192Google Scholar
  34. Seligman MEP, Meier SF, Solomon RL (1971) Unpredictable and uncontrollable aversive events. In: Brush FR (ed) Aversive conditioning and learning. Academic Press, New York, pp 340–400Google Scholar
  35. Sherman AD, Allers GL, Petty F, Henn FA (1979) A neuropharmacologically-relevant animal model of depression. Neuropharmacology 18: 891–893PubMedGoogle Scholar
  36. Simon P, Soubrie P (1979) Behavioral studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs. Mod Probl Pharmacopsychiatry 14: 99–143PubMedGoogle Scholar
  37. Waldmeier PC, Baumann PA, Maitre L (1984) Carbamazepine decreases catecholamine turnover in the rat brain. J Pharmacol Exp Ther 231: 166–172PubMedGoogle Scholar
  38. Weiss JM, Goodman P, Losito BG, Corrigan S, Charry JM, Bailey WH (1981) Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine and serotonin levels in various regions of rat brain. Brain Res 3: 167–205Google Scholar

Literatur

  1. Akimoto HP (1964) Ten years of psychopharmacology: Critical assessment of the present and future. Neuro-Psychopharmacology, Proceedings of the 3rd Meeting of the C. I. N. P., Munich 1962. Elsevier, Amsterdam, pp 552–555Google Scholar
  2. Akiskal HS (1985) A proposed clinical approach to chronic and „resistant“depressions: Evaluation and treatment. J Clin Psychiatry 46: 32–36PubMedGoogle Scholar
  3. Alexander PE, van Kammen DP, Bunney WE (1979) Antipsychotic effects of lithium in schizophrenia. Am J Psychiatry 136: 283–287PubMedGoogle Scholar
  4. Ansseau M, Ansons C, Beckers G, Bogaerts M, Botte L, De Buck R, Diricq S, Dumortier A, Jansegers E, Owieczka J, Stellamons G (1984) Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. J Affective Disord 7: 287–296Google Scholar
  5. Beckmann H, Goodwin FK (1975) Antidepressant response to tricychcs and urinary MHPG in unipolar patients. Arch Gen Psychiatry 32: 17–21PubMedGoogle Scholar
  6. Beckmann H, Haas S (1980) High dose diazepam in schizophrenia. Psychopharmacology 71: 79–82PubMedGoogle Scholar
  7. Bielski RJ, Priedel RO (1976) Prediction of tricyclic antidepressant response. Arch Gen Psychiatry 33: 1479–1483PubMedGoogle Scholar
  8. Black DW, Winokur G, Nasrallah A (1987) The treatment of depression: Electroconvulsive therapy vs antidepressants: A naturalistic evaluation of 1495 patients. Compr Psychiatry 28: 69–182Google Scholar
  9. Chouinard G, Young SN, Annable L (1983) Antimanic effect of clonazepam. Biol Psychiatry 18: 451–466PubMedGoogle Scholar
  10. Cobbin DM, Requin-Blow B, Williams LR, Williams WO (1979) Urinary MHPG levels and tricyclic antidepressant drug selection. Arch Gen Psychiatry 36: 1111–1115PubMedGoogle Scholar
  11. Cookson J, Silverstone T, Wells B (1981) Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis. Acta Psychiatr Scand 64: 381–397PubMedGoogle Scholar
  12. Coppen A (1967) The biochemistry of depression. Br J Psychiatry 113: 1237–1264PubMedGoogle Scholar
  13. Coppen A, Rao VAR, Rathven CRJ, Goodwin BL, Sandler M (1979) Urinary 4-hydroxy-3- methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness. Psychopharmacology 64: 95–97PubMedGoogle Scholar
  14. Davis JM, Friedmann DJ, Linden RD (1983) A review of the new antidepressant medications. In: Davis JM, Maas JW (eds) The affective disorders. American Psychiatric Press, Washington/DC, pp 2–14Google Scholar
  15. Emrich HM, Berger M, Zerssen D v (1985) Differentialtherapie des depressiven Syndroms: Ergebnisse einer Therapiestudie mit Fluvoxamin vs. Oxaprotihn. In: Hippius H, Matussek N (Hrsg) Differentialtherapie der Depression: Möghchkeiten und Grenzen. Advances in Pharmacotherapy, vol 2. Karger, Basel, S 66–73Google Scholar
  16. Emrich HM, Dose M, Zerssen D v (1985) The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affective Disord 8: 243–250Google Scholar
  17. Enkelmann R (1985) Monotherapie ängstlich depressiver Mischbilder mit Alprazolam. Therapiewoche 35:3921–3931Google Scholar
  18. Garver DL, Hirschowitz J, Fleishmann R, Djuric PE (1984) Lithium response and psychoses: A double-blind, placebo-controlled study. Psychiatry Res 12: 57–68PubMedGoogle Scholar
  19. Glassman AH, Kantor SJ, Shostak M (1975) Depression, delusions, and drug response. Am J Psychiatry 132: 716–719PubMedGoogle Scholar
  20. Goldney RD, Spence ND (1986) Safety of the combination of lithium and neuroleptic drugs. Am J Psychiatry 143: 882–884PubMedGoogle Scholar
  21. Goodman WK, Charney DS (1985) Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry 46: 6–22PubMedGoogle Scholar
  22. Goodnick PJ, Meltzer HY (1984) Treatment of schizoaffective disorders. Schizophr Bull 10: 30–48PubMedGoogle Scholar
  23. Hansten PD (1979) Drug interactions. Clinical significance of drug-drug interactions and drug effects on clinical laboratory results, 4th edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  24. Jann MW, Garrelts JC, Ereshefsky L, Saklad SR (1984) Alternative drug therapies for mania: A literature review. Drug Intell Clin Pharm 18: 577–589PubMedGoogle Scholar
  25. Kielholz P, Terzani S, Gastpar M, Adams C (1981) Behandlung therapieresistenter Depressionen ohne Elektroschock. Dtsch Med Wochenschr 106: 671–673PubMedGoogle Scholar
  26. Kissling W (1985) Lithium as an antidepressant. 4th World Congress of Biological Psychiatry, Philadelphia (Abstract)Google Scholar
  27. Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5: 397–408PubMedGoogle Scholar
  28. Klett CJ, Moseley EC (1965) The right drug for the right patient. J Consult Psychol 6: 546–551Google Scholar
  29. Laakmann G, Blaschke D, Hippius H, Messerer D (1986) Wirksamkeits- und Verträglichkeitsvergleich von Alprazolam gegen Amitriptylin bei der Behandlung von depressiven Patienten in der Praxis des niedergelassenen Allgemein- und Nervenarztes. In: Hippius H, Engel RR, Laakmann G (Hrsg) Benzodiazepine: Rückblick und Ausblick. Springer, Berlin Heidelberg New York Tokyo, S 139–147Google Scholar
  30. Lackroy GH, van Praag HM (1971) Lithium salts as sedatives. Acta Psychiatr Scand 47: 163–173PubMedGoogle Scholar
  31. Lerer B (1985) Alternative therapies for bipolar disorder. J Clin Psychiatry 46: 309–316PubMedGoogle Scholar
  32. Lewis JL, Winokur G (1982) The induction of mania. A natural history study with controls. Arch Gen Psychiatry 39: 303–306PubMedGoogle Scholar
  33. Lingjaerde O (1982) Effect of the benzodiazepine derivative estazolam in patients with auditory hallucinations. Acta Psychiatr Scand 65: 339–354PubMedGoogle Scholar
  34. Lingjaerde O, Engstrand E, Ellingsen P, Stylo DA, Robak OH (1979) Antipsychotic effect of diazepam when given in addition to neuroleptics in chronic psychotic patients: A double-blind clinical trial. Curr Ther Res 26: 505–514Google Scholar
  35. Maas JW, Koslow SH, Katz MM, Bowden CL, Gibbons RL, Stokes PE, Robins E, Davis JM (1984) Pretreatment neurotransmitter metabolite levels and response to tricychc antidepressant drugs. Am J Psychiatry 141: 1159–1171PubMedGoogle Scholar
  36. McCabe B, Tsuang MT (1982) Dietary consideration in MAO inhibitor regimens. J Clin Psychiatry 43:178–181PubMedGoogle Scholar
  37. Nestoros JN, Nair NPV, Pulman JR, Schwartz G, Bloom D (1983) High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients. Psychopharmacology 81: 42–47PubMedGoogle Scholar
  38. Nies A (1984) Differential response patterns to MAO inhibitors and tricychcs. J Clin Psychiatry 45: 70–77PubMedGoogle Scholar
  39. Nystroem C, Haellstroem T (1985) Double-blind comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Acta Psychiatr Scand 72: 6–15Google Scholar
  40. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe M (1979) Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study. Psychopharmacology 66: 211–217PubMedGoogle Scholar
  41. Overall JE, Hollister LE, Meyer F, Kimbell I jr, Shelton J (1964) Imipramine and thioridazine in depressed and schizophrenic patients. JAMA 189: 605–608PubMedGoogle Scholar
  42. Overall JE, Hollister LE, Johnson M, Pennington V (1966) Nosology of depression and differential response to drugs. JAMA 195: 162–164Google Scholar
  43. Paykel ES, Price JS, Gillan RU, Palmai G, Chesser ES (1968) A comparative trial of Imipramine and chlorpromazine in depressed patients. Br J Psychiatry 114: 1281–1287PubMedGoogle Scholar
  44. Potter WZ, Karoum F, Linnoila M (1984) Common mechanism of action of biochemically „specific“antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 8: 153–161PubMedGoogle Scholar
  45. Praag HM van (1981) Management of depression with serotonin precursors. Biol Psychiatry 16: 291–310PubMedGoogle Scholar
  46. Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes: How long should it be maintained? Am J Psychiatry 143: 18–23PubMedGoogle Scholar
  47. Puzynski S, Rode A, Bidzinski A, Mrozek S, Zaluska M (1984) Failure to correlate urinary MHPG with clinical response to amitriptyline. Acta Psychiatr Scand 69: 117–120PubMedGoogle Scholar
  48. Quitkin FM (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147: 593–597PubMedGoogle Scholar
  49. Rickels K, Feighner JP, Smith WT (1985) Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry 42: 134–141PubMedGoogle Scholar
  50. Robertson MM, Trimble MR (1982) Major tranquillisers used as antidepressants. A review. J Affective Disord 4: 173–193Google Scholar
  51. Sargant W (1962) The treatment of anxiety states and atypical depression by the monoamine oxidase inhibitor drugs. Neuropsychiatria 3 (Suppl 1): 96–103Google Scholar
  52. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509–522PubMedGoogle Scholar
  53. Sharma IJ, Venkitasubramanian TA, Agnihotri BR (1986) 3-MHPG as a non-predictor of antidepressant response to Imipramine and electroconvulsive therapy. Acta Psychiatr Scand 74: 252–254PubMedGoogle Scholar
  54. Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin J, Neil JF, Perce JM, Rossi AJ, Soloff PH (1985) The pharmacological treatment of delusional depression. Am J Psychiatry 142: 430–436PubMedGoogle Scholar
  55. Stern SL, Mendels J (1981) Drug Combinations in the treatment of refractory depression: A review J Clin Psychiatry 42: 368–373PubMedGoogle Scholar
  56. Woggon B (1987) Psychopharmakotherapie affektiver Psychosen. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart. 3. Aufl, Bd 5, Affektive Psychosen. Springer, Berlin Heidelberg New York London Paris Tokyo, S 273–325Google Scholar
  57. Young JPR, Hughes WC, Lader MH (1976) A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br Med J 1: 1116–1118PubMedGoogle Scholar

Literatur

  1. Ahlfors UG, Baastrup PC, Decker SJ et al. (1981) Flupenthixol decanoate in recurrent manic- depressive illness. Acta Psychiat Scand 64: 226–237PubMedGoogle Scholar
  2. Baastrup PC (1964) The use of lithium in manic-depressive psychosis. Compr Psychiatry 5: 396–408Google Scholar
  3. Baastrup PC, Schou M (1967) Lithium as a prophylactic agent: Its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 16: 162–172PubMedGoogle Scholar
  4. Bernasconi R (1982) The GABA hypothesis of affective illness. Influence of clinically effective antimanic drugs on GABA turnover. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam, pp 183–192Google Scholar
  5. Cade JFJ (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2: 349–352PubMedGoogle Scholar
  6. Coppen A, Montgomery SA, Gupta RK, Bailey JE (1976) A double-bhnd comparison of lithium carbonate and maprotihne in the prophylaxis of affective disorders. Br J Psychiatry 128:479–485PubMedGoogle Scholar
  7. Coppen A, Ghose K, Rao R, Bailey J, Peet M (1978) Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry 133: 206–210PubMedGoogle Scholar
  8. Cording-Tömmel C, Wittchen H-U, Zerssen Dv (1988) Evaluation des Verlaufs und Outcomes affektiver Psychosen. Implikationen für eine patientenorientierte Bedarfsplanung. In: Zweifel B (Hrsg) Beiträge zur Gesundheitsökonomie, Band 14: Neue Ansätze der Bedarfsforschung. Bleicher, Gerlingen (im Druck)Google Scholar
  9. Emrich HM, Cording C, Piree S, Kölling A, Zerssen D v, Herz A (1977) Indication of an antipsychotic action of the opiate antagonist naloxone. Pharmacopsychiatria 10: 265–270Google Scholar
  10. Emrich HM, Zerssen D v, Möller H-J, Kissling W, Cording C, Schietsch HJ, Riedel E (1979) Action of propranolol in mania: Comparison of effects of the d- and the 1-stereoisomer. Pharmacopsychiatria 12: 295–304Google Scholar
  11. Emrich HM, Dose M, Zerssen Dv (1985) The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affective Disord 8: 243–250Google Scholar
  12. Giedke H, Coenen T (1986) Die medikamentöse Behandlung von Angstzuständen. In: Janke W, Netter P (Hrsg) Angst und Psychopharmaka. Kohlhammer, Stuttgart, S 207–234Google Scholar
  13. Glen AIM, Johnson AL, Shepherd M (1981) Continuation therapy with lithium and amitriptyhne in unipolar depressive illness: A controlled clinical trial. Psychol Med 11: 409–416Google Scholar
  14. Goodwin FK, Murphy DL, Bunney WE Jr (1969) Lithium-carbonate treatment in depression and mania. Arch Gen Psychiatry 21: 486–495PubMedGoogle Scholar
  15. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi R, Nayak DD, Howard A (1982) Lithium carbonate and Imipramine in the prophylaxis of unipolar and bipolar II illness. Arch Gen Psychiatry 39: 1065–1069PubMedGoogle Scholar
  16. Klein D (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5: 397–408PubMedGoogle Scholar
  17. Klerman GL, DiMascio A, Weissman M, Prusoff B, Paykel ES (1974) Treatment of depression by drugs and psychotherapy. Am J Psychiatry 131: 186–191PubMedGoogle Scholar
  18. Lambert P-A (1984) Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HM, Okuma T, Müller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp 33–44Google Scholar
  19. Lambert P-A, Carraz G, Borselli S, Carrel S (1966) Action neuropsychotrope d’un novel antiepilepti- que: le Depamide. Ann Med Psychol (Paris) 1: 707–710Google Scholar
  20. Lambert P-A, Carraz G, Borselli S, Bouchardy M (1975) Le dipropylacetamide dans le traitement de la psychose maniaco-dépressive. Encephale 1: 25–31PubMedGoogle Scholar
  21. Mindham RH, Howland C, Shepherd M (1973) An evaluation of continuation therapy with tricychc antidepressants in depressive illness. Psychol Med 3: 5–17PubMedGoogle Scholar
  22. Montgomery SA, Montgomery D (1982) Pharmacological prevention of suicidal behaviour. J Affective Disord 4: 291–298Google Scholar
  23. Müller-Oerlinghausen B, Greil W (Hrsg) (1986) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  24. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A, Matsushita T, Nakao T, Ogura C (1973) Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychoses. A preliminar report. Foha Psychiatr Neurol Jpn 27: 283–297Google Scholar
  25. Okuma T, Inanaga K, Otsuki S, Sarai K, Takahashi R, Hazama H, Mori A, Watanabe M (1981) A preliminary double-blind study of the efficacy of carbamazepine in prophylaxis of manic- depressive illness. Psychopharmacology 73: 95–96PubMedGoogle Scholar
  26. Paykel ES, DiMascio A, Haskell D, Prusoff BA (1975) Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychol Med 5: 67–77PubMedGoogle Scholar
  27. Placidi GF, Lenzi A, Rampello E, Andreani MF, Cassano GB, Grossi E (1984) Long-term double bhnd prospective study on carbamazepine versus lithium in bipolar and schizoaffective disorders. Preliminary results. In: Emrich HM, Okuma T, Müller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp 188–197Google Scholar
  28. Post RM, Uhde TW (1983) Treatment of mood disorders with antiepileptic medications: Clinical and theoretical implications. Epilepsia 24 [Suppl]: 97–108Google Scholar
  29. Post RM, Uhde TW, Ballenger JC, Squillace KM (1983) Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 140: 1602–1604PubMedGoogle Scholar
  30. Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes: How long should it be maintained? Am J Psychiatry 143: 18–23PubMedGoogle Scholar
  31. Prien RF, Klett CH, Caffey EM (1973) Lithium carbonate and Imipramine in prevention of affective episodes. Arch Gen Psychiatry 29: 420–425PubMedGoogle Scholar
  32. Pużyński S, Klosiewicz L (1984) Valproic acid amide as a prophylactic agent in affective and schizoaffective disorder. In: Emrich HM, Okuma T, Müller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp 68–75Google Scholar
  33. Rackensperger W, Fritsch W, Schwarz D, Stutte KH, Zerssen Dv (1976) Wirkung des Beta- Rezeptoren-Blockers Propranolol auf Manien. Arch Psychiatr Nervenkr 222: 223–243PubMedGoogle Scholar
  34. Rüther E, Hippius H (1982) Neuroleptika in niedriger Dosierung als Tranquilizer? MMW 124: 683–684Google Scholar
  35. Schou M (1971) Die Lithiumprophylaxe bei manisch-depressiven Psychosen. Nervenarzt 42: 1–10PubMedGoogle Scholar
  36. Schou M (1983) Prophylaktische Lithiumbehandlung bei manisch-depressiver Krankheit: Erfahrungen und Fortschritte der letzten Jahre. Nervenarzt 54: 331–339PubMedGoogle Scholar
  37. Strömgren LS, Boller S (1985) Carbamazepine in treatment and prophylaxis of manic-depressive disorder. Psychiatr Dev 3: 349–367PubMedGoogle Scholar
  38. Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, Kearns GL, Stull JD, Bove KE (1979) Acute hepatic failure associated with the use of sodium valproate. New Engl J Med 300: 962–966PubMedGoogle Scholar
  39. Takezaki H, Hanaoka M (1971) The use of carbamazepine (Tegretol) in the control of manic- depressive psychosis and other manic-depressive states. Clin Psychiatry Jpn 13: 173–183Google Scholar
  40. Tyrer P, Lader M (1974) Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J 2: 14–16PubMedGoogle Scholar
  41. Tyrer P, Steinberg D (1975) Symptomatic treatment of agoraphobia and social phobias: a follow-up study. Br J Psychiatry 127: 163–168PubMedGoogle Scholar
  42. Vassout A, Delini-Stula A (1977) Effects de ß-bloquers (propranolol et Oxprenolol) et du diazepam sur différents modèles d’agressivité chez le rat. J Pharmacol 8: 5–14Google Scholar
  43. Vencovsky E, Souček K, Kabeš J (1984) Prophylactic effect of dipropylacetamide in patients with bipolar affective disorders. In: Emrich HM, Okuma T, Müller AA (eds) Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam, pp 66–67Google Scholar
  44. Willmore LJ, Wilder BJ, Bruni J, Villarreal HJ (1978) Effect of valproic acid on hepatic function. Neurology 28: 961–964PubMedGoogle Scholar
  45. Zerssen Dv (1976) Beta-adrenergic blocking agents in the treatment of psychoses. A report on 17 cases. In: Carlsson C, Engel J, Hansson L (eds) Neuro-psychiatric effect of adrenergic beta- receptor blocking agents. Urban & Schwarzenberg, München, pp 105–114Google Scholar

Literatur

  1. Amenson CS, Lewinsohn PM (1981) An investigation into the observed sex differences in prevalence of unipolar depression. J Abnorm Psychol 90: 1–13PubMedGoogle Scholar
  2. Beck AT (1967) Depression: Clinical, experimental, and theoretical aspects. Harper & Row, New YorkGoogle Scholar
  3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 53–63Google Scholar
  4. Beck AT, Rush AJ, Shaw BF, Emery G (1979) Cognitive therapy of depression. Guilford, New YorkGoogle Scholar
  5. Berbalk H, Goedtke J, Ninnemann S (1984) Ängsthchkeit und Wahrnehmung sozialer Situationen. Verbindungen zwischen der Extraversionstheorie von Gray und attributionstheoredschen Erklärungsansätzen zur Depression. Z Different Diagn Psychol 5: 171–182Google Scholar
  6. Blöschl L (1978) Psychosoziale Aspekte der Depression. Huber, BernGoogle Scholar
  7. Bower G (1981) Mood and memory. Am J Psychol 36: 129–148Google Scholar
  8. Cattell RB (1959) Personahty and motivation structure and measurement. World Book, New YorkGoogle Scholar
  9. Eysenck HJ (1970) The structure of human personality. Methuen, LondonGoogle Scholar
  10. Eysenck HJ, Eysenck SBG (1964) Manual of the Eysenck Personahty Inventory. London University Press, LondonGoogle Scholar
  11. Ferster CB (1965) Classification of behavior pathology. In: Krasner L, Ullman SP (eds) Research in behavior modification. Holt Rinehart & Winston, New York, pp 6–26Google Scholar
  12. Garber J, Seligman MEP (1980) (eds) Human helplessness. Theory and applications. Academic Press, New York London Toronto Sydney San FranciscoGoogle Scholar
  13. Gray JA (1982) The neuropsychology of anxiety. Clarendon, OxfordGoogle Scholar
  14. Hellhammer D (1983) Learned helplessness. An animal model revisited. In: Angst J (ed) The origins of depression: Current concepts and approaches. Springer, Berlin Heidelberg New York Tokyo, pp 147–161Google Scholar
  15. Jöreskog KG, Sörbom D (1981) Analysis of linear structural relationships by maximum likelihood and last squares methods: User’s guide. International Educational Services, ChicagoGoogle Scholar
  16. Jöreskog KG, Sörbom D (1985) LISREL VI. User’s guide. Scientific Software, Mooresville/INGoogle Scholar
  17. Lewinsohn PM, Youngren MA, Grosscup SJ (1979) Reinforcement and depression. In: Depue RA (ed) The psychobiology of depressive disorders: Implications for the effect of stress. Academic Press, New York London Toronto Sydney San Francisco, pp 89–106Google Scholar
  18. Lewinsohn PM, Teri L, Hoberman H (1983) Depression: A perspective on etiology, treatment, and life span issues. In: Rosenbaum M, Franks D, Jaffe Y (eds) Advances in behavior therapy. Springer, Berlin Heidelberg New York Tokyo, pp 64–76Google Scholar
  19. Lewinsohn PM, Hoberman H, Teri L, Hautzinger M (1985) An integrative theory of depression. In: Reiss S, Bootzin RR (eds) Theoretical issues in behavior therapy. Academic Press, New York London Toronto Sydney San Francisco, pp 331–359Google Scholar
  20. Markus H (1977) Self-schemata and processing of information about the self. J Pers Soc Psychol 35: 63–78Google Scholar
  21. McKinney WT (1974) Animal models in psychiatry. Perspect Biol Med 17: 529–541PubMedGoogle Scholar
  22. Paykel ES, Myers JK, Dienelt MN, Klerman GL, Lindenthal JJ, Pepper MP (1969) Life events and depression: A controlled study. Arch Gen Psychiatry 21: 753–760PubMedGoogle Scholar
  23. Peterson C, Semmel A, Metalsky G, Abramson LY, Baeyer CV, Sehgman MEP (1982) The attributional style questionaire. Cogn Ther Res 6: 287–300Google Scholar
  24. Seligman MEP (1975) Helplessness: On depression, development and death. Freeman, San FranciscoGoogle Scholar
  25. Sigrist J, Dittmann U (1981) Lebensveränderung und Krankheitsausbruch: Methodik und Ergebnisse einer medizinsoziologischen Studie. Köln Z Soziol Sozialpsychol 1: 1–58Google Scholar
  26. Steinmeyer EM (1984) Depression und gelernte Hilflosigkeit. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  27. Teasdale JD (1983) Affect and accessibihty. Philos Trans R Soc Lond 302: 403–412Google Scholar
  28. Teasdale JD, Taylor R, Fogarty SJ (1980) Effects of induced elation-depression on the accessibihty of memories of happy and unhappy experiences. Behav Res Ther 18: 339–346PubMedGoogle Scholar
  29. Tellenbach H (1961) Melancholie. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  30. Ullrich R, Ullrich R (1977) Der Unsicherheitsfragebogen. Pfeiffer, MünchenGoogle Scholar
  31. Wölpe J (1981) Die neurotische Depression: Experimentelles Analogon, klinische Syndrome und Behandlung. In: Blöschl L (Hrsg) Verhaltenstherapie depressiver Reaktionen. Huber, Berlin Stuttgart Wien, S 255–266Google Scholar
  32. Zerssen Dv (1976) Die Befindlichkeits-Skala. Manual. Beltz Test, WeinheimGoogle Scholar
  33. Zerssen Dv (1976) Die Depressivitäts-Skala. Manual. Beltz Test, WeinheimGoogle Scholar

Literatur

  1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. APA, Washington/DCGoogle Scholar
  2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571PubMedGoogle Scholar
  3. Beck AT, Hollon SD, Young JE, Bedrosian RC, Budenz D (1985) Treatment of depression with cognitive therapy and amitriptyhne. Arch Gen Psychiatry 42: 142–148PubMedGoogle Scholar
  4. Beck AT, Rush AJ, Shaw BF, Emery G (1986) Kognitive Therapie der Depression, 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  5. Bellack AS, Hersen M, Himmelhoch J (1981) Social skills training compared with pharmacotherapy and psychotherapy in the treatment of unipolar depression. Am J Psychiatry 138: 1562–1567PubMedGoogle Scholar
  6. Blackburn IM, Bishop S (1981) Is there an alternative to drugs in the treatment of depressed ambulatory patients? Behav Psychother 9: 96–104Google Scholar
  7. Blackburn IM, Bishop S, Glen AJM, Whalley LJ, Christie JE (1981) The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacological therapy, each, alone, and in combination. Br J Psychiatry 139: 181–189PubMedGoogle Scholar
  8. Blackburn IM, Eunson KM, Bishop S (1986) A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affective Disord 10: 67–75Google Scholar
  9. Brengelmann JC, Brengelmann L (1960) Deutsche Validierung von Fragebogen der Extraversion, neurotischer Tendenz und Rigidität. Z Exp Angew Psychol 7: 291–331Google Scholar
  10. Brown RA, Lewinsohn PM (1984) A psychoeducational approach to the treatment of depression comparison of group, individual and minimal contact procedures. Unpublished manuscript. University of OregonGoogle Scholar
  11. Comasz-Dias L (1981) Effects of cognitive and behavioral group treatment on the depressive symptomatology of puertorican women. J Consult Clin Psychol 49: 627–632Google Scholar
  12. Conte HR, Plutchik R, Wild KV, Karasu TB (1986) Combined psychotherapy and pharmacotherapy for depression. Arch Gen Psychiatry 43: 471–479PubMedGoogle Scholar
  13. Degkwitz R, Helmchen H, Kockott G, Mombour W (Hrsg) (1980) Diagnosenschlüssel und Glossar psychiatrischer Krankheiten, 9. Revision, 5. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  14. Ellgring H, Derbolowsky J, Devitz A v, Hieke S (1978) Standardisiertes Interview zur Verhaltensbeobachtung depressiver Erkrankungen (SID). Max-Planck-Institut für Psychiatrie, MünchenGoogle Scholar
  15. Ellis A, Grieger R (1979) Praxis der rational-emotiven Therapie. Urban & Schwarzenberg, MünchenGoogle Scholar
  16. Fahrenberg J, Selg H, Hampel R (1978) Das Freiburger Persönhchkeiknventar (FPI), 3. Aufl. Handanweisung. Hogrefe, GöttingenGoogle Scholar
  17. Fennell MJV, Teasdale JD (1982) Cognitive therapy with chronic, drug-refractory depressed outpatients: A note of caution. Cogn Ther Res 6: 455–460Google Scholar
  18. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 276–296Google Scholar
  19. Hand E, Wittchen H-U (eds) (1986) Panic and phobias. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  20. Harpin RE, Liberman RP, Marks I, Stern R, Bohannon WE (1982) Cognitive behavior therapy for chronically depressed patients: A controlled pilot study. J Nerv Ment Dis 170: 295–301PubMedGoogle Scholar
  21. Hautzinger M (1985 a) Cognitive behavior therapy with depressed outpatients. Unveröffentlichtes Vortragsmanuskript, 15th EABT Convention, MünchenGoogle Scholar
  22. Hautzinger M (1985b) Skalen dysfunktionaler Einstellungen. Eine deutsche Version der Dysfunctional Attitude Scale. Diagnostica 31: 312–323Google Scholar
  23. Herceq-Baron RL, Prusoff BA, Weissman MM, Di Mascio A, Neu C, Klerman GL (1979) Pharmacotherapy and psychotherapy in acutely depressed patients: A study of attribution patterns in a clinical trial. Compr Psychiatry 20: 315–325Google Scholar
  24. Innerhofer P, Warnke A (1978) Eltern als Co-Therapeuten. Springer, Berlin Heidelberg New YorkGoogle Scholar
  25. Jong de R (1986) Das Ansprechen auf verhaltenstherapeutisch-kognitive Behandlung bei Untergruppen depressiver Patienten mit einer ungünstigen Prognose. Verhaltensmodifikation 3: 152–168Google Scholar
  26. Jong de R, Henrich G, Ferstl R (1981) A behavioral treatment program for neurotic depression. J Behav Anal Modif 4: 275–287Google Scholar
  27. Jong de R, Henrich G, Treiber R (1983) Die Effekte von zwei psychologischen Therapien bei schwer neurotisch-depressiven Patienten. In: Brengelmann JC (Hrsg) Therapieforschung für die Praxis 2. IFT-Texte 10. Röttger, München, S 117–139Google Scholar
  28. Jong de R, Treiber R, Henrich G (1986) Effectiveness of two psychological treatments for inpatients with severe and chronic depressions. Cogn Ther Res 10: 645–663Google Scholar
  29. Klerman GL, Rounsaville B, Chevron E, Neu C, Weissman M (1978) Manual for short-term interpersonal psychotherapy (IPT) of depression. Manuscript. Newhaven/CTGoogle Scholar
  30. Kovacs M, Rush AJ, Beck AT, Hollon ST (1981) Depressed outpatients treated with cognitive therapy or pharmacotherapy. Arch Gen Psychiatry 38: 33–39PubMedGoogle Scholar
  31. Lang PJ, Levin DN, Miller GA, Kozak MJ (1983) Fear behavior, fear imagery, and the psychophysiology of emotion: The problem of affective response integration. J Abnorm Psychol 92: 276–306PubMedGoogle Scholar
  32. Lorr M, Klett CJ (1967) Manual for the Inpatient Multidimensional Psychiatric Rating Scale (revised). Consulting Psychologist Press, Palo Alto/CAGoogle Scholar
  33. Luka U (1985) Modification of depressive cognitions Unveröffentlichtes Vortragsmanuskript, 15th EABT Convention, MünchenGoogle Scholar
  34. Mascio Di A, Weissman MM, Prusoff BA, Neu C, Zwilhng M, Klerman GL (1979) Differenüal symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 36: 1450–1456Google Scholar
  35. May PRA, Putten van TV (1974) Treatment of schizophrenia: II. A proposed rating scale of design and outcome for use in literature surveys. Compr Psychiatry 15: 267–275PubMedGoogle Scholar
  36. McLean PD, Hakstian AR (1979) Clinical depression: comparative efficacy of outpatient treatments. J Consult Clin Psychol 47: 818–836PubMedGoogle Scholar
  37. Meichenbaum D (1979) Kognitive Verhaltensmodifikation. Urban & Schwarzenberg, MünchenGoogle Scholar
  38. Morris NE (1975) A group self-instrucüon method for the treatment of depressed outpatients. Dissertation, National Library of Canada, Canadian Theses Division, No 35272Google Scholar
  39. Murphy GE, Simons AD, Wetzes RD, Lustman PJ (1984) Cognitive therapy and pharmacotherapy. Arch Gen Psychiatry 41: 33–41PubMedGoogle Scholar
  40. Niebel G, Wiegand CH (1987) Entwicklung und Evaluation eines gestuften verhaltenstherapeutischen Programms für depressive Patienten. In: Miltner W, Gerber WD, Mayer K (Hrsg) Verhaltensmedizin: Ergebnisse und Perspektiven interdisziplinärer Forschung. VCH, Weinheim, S 515–535Google Scholar
  41. Petermann U, Petermann F (1984) Training mit aggressiven Kindern, 2. Aufl. Urban & Schwarzenberg, MünchenGoogle Scholar
  42. Rachman SJ, Wilson GT (1980) The effects of psychological therapy. Pergamon, OxfordGoogle Scholar
  43. Rötzer-Zimmer FT, Axmann D, Koch H, Giedke H, Pflug B, Heimann H (1985) One year follow-up of cognitive behaviour therapy for depressed patients: A comparison of cognitive behavioural therapy done, in combination with pharmacotherapy and pharmacotherapy done. Paper presented at the 15th Annual Meeting of the European Association for Behaviour Therapy, MünchenGoogle Scholar
  44. Rötzer-Zimmer FT, Serra E, Pflug B, Heimann H (1987) Änderungsprozesse in der Depressionsbehandlung-Kognitive Verhaltenstherapie alleine und in Kombination mit Pharmakotherapie. In: Miltner W, Gerber WD, Mayer K (Hrsg) Verhaltensmedizin: Ergebnisse und Perspektiven interdisziplinärer Forschung. VCH, Weinheim, S 563–579Google Scholar
  45. Roth P, Bielski R, Jones M, Parker W, Osborn F (1982) A comparison of self-control therapy and combined self-control therapy and antidepressant medication in the treatment of depression. Behav Ther 13: 133–144Google Scholar
  46. Rush AJ, Watkins JT (1981) Group versus cognitive therapy: A pilot study. Cog Ther Res 5: 95–103Google Scholar
  47. Rush AJ, Beck AT, Kovacs M, Hollon SD (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of cognitive therapy and pharmacotherapy of depressed outpatients. Cogn Ther Res 1: 17–37Google Scholar
  48. Schlottke PF, Wetzel H (Hrsg) (1980) Psychologische Behandlung von Kindern und Jugendhchen. Urban & Schwarzenberg, MünchenGoogle Scholar
  49. Shaw B (1977) Comparison of cognitive therapy and behavior therapy in the treatment of depression. J Consult Clin Psychol 45: 543–551PubMedGoogle Scholar
  50. Simons AD, Murphy GE, Levine JL, Wetzel RD (1986) Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43: 43–48PubMedGoogle Scholar
  51. Spitzer R et al. (1978) Research Diagnostic Criteria: Rationale and rehabihty. Arch Gen Psychiatry 135: 773–782Google Scholar
  52. Teasdale JD, Fennel MJV, Hibbert GA, Amies PL (1984) Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry 144: 400–406PubMedGoogle Scholar
  53. Ullrich R, Ullrich R (1977) Der Unsicherheitsfragebogen. Testmanual. Pfeiffer, MünchenGoogle Scholar
  54. Weissman MM, Klerman GL, Paykal ES, Hanson B (1974) Treatment effects on the social adjustment of depressed patients. Arch Gen Psychiatry 30: 771–778PubMedGoogle Scholar
  55. Weissman MM, Kasl SU, Klerman GL (1976) Follow-up of depressed women after maintenance treatment. Am J Psychiatry 133: 757–760PubMedGoogle Scholar
  56. Weissman MM, Klerman GL, Prusoff BA, Sholomskas D, Padian N (1981) Depressed outpatients: Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 38: 51–55PubMedGoogle Scholar
  57. Wilson PH (1982) Combined pharmacological and behavioral treatment of depression. Behav Res Ther 20: 173–184PubMedGoogle Scholar
  58. Wilson PH, Goldin JC, Charbonneau-Powis M (1983) Comparative efficacy of depression. Cogn Ther Res 7: 111–124Google Scholar
  59. Zeiss AM, Lewinsohn PM, Muñoz RF (1979) Nonspecific improvement effects in depression using interpersonal skills training, pleasant activity schedules, or cognitive training. J Consult Clin Psychol 47: 427–439PubMedGoogle Scholar
  60. Zerssen Dv (1976) Khnische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchener Psychiatrischen Informationssystem (PSYCHIS München). Manuale. Beltz, WeinheimGoogle Scholar

Literatur

  1. Alexander F, French TM (1946) Psychoanalytic therapy. Ronald, New YorkGoogle Scholar
  2. Balint M, Ornstein PH, Balint E (1972) Focal psychotherapy. Tavistock, LondonGoogle Scholar
  3. Beckmann D, Richter HE (1972) Giessen-Test. Huber, BernGoogle Scholar
  4. Bolz W, Meyer A-E (1981) I. The general setting. Psychother Psychosom 35: 85–95PubMedGoogle Scholar
  5. Eysenck, HJ (1952) The effects of psychotherapy: An evaluation. J Consult Clin Psychol 16:319–324Google Scholar
  6. Fahrenberg J, Selg H (1970) Das Freiburger Persönlichkeitsinventar. Hogrefe, GöttingenGoogle Scholar
  7. Grawe K (1976) Différentielle Psychotherapie I. Huber, Bern Stuttgart WienGoogle Scholar
  8. Kiesler D (1966) Some myths of psychotherapy research and the search for a paradigm. Psychol Bull 65: 110–136Google Scholar
  9. Kiesler D (1969) A grid model for theory and research in the psychotherapies. In: Eron LD, Callahan R (eds) The relation of therapy to practice in psychotherapy. Aldine, Chicago, pp 115–145Google Scholar
  10. Kimm JJ, Bolz W, Meyer A-E (1981) The patient sample: Overt and covert selection factors and prognostic predictions, pp 98–109 Psychother PsychosomGoogle Scholar
  11. Kohut H (1979) Die Heilung des Selbst. Suhrkamp, FrankfurtGoogle Scholar
  12. Luborski L, Singer B, Luborski L (1975) Comparative studies of psychotherapy. Is it true that „everybody has won and all must have prizes? “Arch Gen Psychiatry 32: 995–1008Google Scholar
  13. Malan DH (1963) A study of brief psychotherapy. Tavistock, LondonGoogle Scholar
  14. Malan DH (1976). The frontiers of brief psychotherapy. Plenum, New York LondonGoogle Scholar
  15. Meyer A-E (ed) (1981) The Hamburg Short Psychotherapy Comparison Experiment. Psychother Psychosom 35: 81–207Google Scholar
  16. Meyer A-E (1984) Grundlagen, Konzepte und Methoden der Psychotherapieforschung. Verh Dtsch Ges Inn Med 90: 417–422Google Scholar
  17. Meyer A-E (1987 a) Psychotherapieforschung: Schulenwettstreit oder Prozeß-Effizienz-Forschung (In Vorb)Google Scholar
  18. Meyer A-E (1987b) Was wirkt in der Psychotherapie? In: Lang, H (Hrsg) Wirkfaktoren der Psychotherapie. Springer, Berlin Heidelberg London Paris Tokyo (im Druck)Google Scholar
  19. Meyer A-E, Niemann I (1984) Problèmes hés à la limitation à un maximum de 30 séances, préalablement communiquées au patient, dans deux formes de psychothérapies brèves. Psychothérapies 1: 81–93Google Scholar
  20. Migone P (1985) Short-term dynamic psychotherapy from a psychoanalytic viewpoint. Psychoanal Rev 72: 615–634PubMedGoogle Scholar
  21. Möller H-J, Zerssen Dv (1986) Diagnostik von Depression und Angst mit standardisierten Beurteilungsverfahren. In: Helmchen H, Linden M (Hrsg). Die Differenzierung von Angst und Depression. Springer, Berlin Heidelberg New York Tokyo S 15–31Google Scholar
  22. Nicholson RA, Berman JS (1983) Is follow-up necessary in evaluating psychotherapy? Psychol Bull 93: 261–278PubMedGoogle Scholar
  23. Niemann I (1980) Zur Bedeutung einer Gesamtstundenbegrenzung bei Kurzpsychotherapien anhand eines Vergleiches zwischen psychodynamischer Kurztherapie und Gesprächstherapie. Med Diss, Universität HamburgGoogle Scholar
  24. Paul GL (1967) Strategy of outcome research in psychotherapy. J Consult Clin Psychol 31: 109–118Google Scholar
  25. Plog U (1976) Différentielle Psychotherapie II Huber, Bern Stuttgart WienGoogle Scholar
  26. Rogers CR (1942) Counselling and psychotherapy. Houghton & Mifflin, BostonGoogle Scholar
  27. Rogers CR (1951) Client-centered therapy. Houghton & Mifflin, BostonGoogle Scholar
  28. Rogers CR (1961) On becoming a person. Houghton & Mifflin, New YorkGoogle Scholar
  29. Sloane RB, Staples FR, Christel AH, Yorkston NJ, Wipple K (1975) Psychotherapy versus behavior therapy. Harvard University Press, CambridgeGoogle Scholar
  30. Smith ML, Glass GV, Miller IT (1980) The benefits of psychotherapy. John Hopkins University Press, Baltimore.Google Scholar
  31. Spreen O (1961) Konstruktion einer Skala zur Messung der manifesten Angst in experimentellen Untersuchungen. Psychol Forsch 26: 205–223Google Scholar
  32. Strupp HH, Bergin AE (1969) Some empirical and conceptual basis for coordinated research in psychotherapy: A critical review of issues, trends and evidence. Int J Psychiatry Med 7: 18–90Google Scholar
  33. Tausch R (1973) Gesprächspsychotherapie, 5. Aufl. Hogrefe, GöttingenGoogle Scholar
  34. Tausch R (1978) Personzentrierte Gesprächspsychotherapie. In: Pongratz LJ (Hrsg) Handbuch der Psychologie, Bd 8. Hogrefe, Göttingen, S 1911–1954Google Scholar
  35. Wittmann WW, Matt G (1986) Meta-Analyse als Integration von Forschungsergebnissen am Beispiel deutschsprachiger Arbeiten zur Effektivität von Psychotherapie. Psychol Rundschau 37: 20–40Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • A. Delini-Stula
  • B. Woggon
  • H. M. Emrich
  • M. Dose
  • E. M. Steinmeyer
  • R. de Jong-Meyer
  • A.-E. Meyer
  • U. Wirth

There are no affiliations available

Personalised recommendations